Anti-TNF
Anti-TNF therapy in Jordan: a focus on severe infections and tuberculosis
... of anti-TNF treatment was ...one anti-TNF agent was given in ...different anti-TNF agents for the duration of ...one anti-TNF agent was the only factor associated ...
6
Anti TNF immunotherapy and tuberculosis reactivation: another mechanism revealed
... lymphocytes (see the related article beginning on page 1167). The authors report that a granulysin-expressing CD45RA + subset of effector memory CD8 + T cells that contributes to the killing of intracellular M. ...
5
An anti TNF α antibody mimetic to treat ocular inflammation
... An anti TNF α antibody mimetic to treat ocular inflammation SCIENTIFIC REPORTS | 6 36905 | DOI 10 1038/srep36905 www nature com/scffientffifffficreports 1 An antffi TNF α antffibody mffimetffic to tre[.] ...
10
Anti–TNF-α Therapy May Cause Neonatal Neutropenia
... Although anti – tumor necrosis factor (anti-TNF) antibodies are asso- ciated with a clear risk of agranulocytosis in adults and are known to cross the placenta, monitoring of the absolute neutrophil ...
7
The immunogenicity to the first anti TNF therapy determines the outcome of switching to a second anti TNF therapy in spondyloarthritis patients
... first anti-TNF drug have been reported in the literature, including shorter disease duration, younger age, HLA-B27 positivity, a lower Bath Ankylos- ing Spondylitis Functional Index score, higher C-reactive ...
7
Chronic exposure to tumor necrosis factor (TNF) in vitro impairs the activation of T cells through the T cell receptor/CD3 complex; reversal in vivo by anti TNF antibodies in patients with rheumatoid arthritis
... chimeric anti-TNF mAb. Treatment with anti-TNF restored the diminished proliferative responses of PBMC to mitogens and recall antigens towards normal in all patients ...of TNF in vitro ...
13
An anti TNF α antibody mimetic to treat ocular inflammation
... of anti-TNF therapies, in particular when delivered systemically for treatment of uveitis associated with systemic disorders ...target TNF- α through intravitreal (IVT) ...target TNF- α have ...
32
Effects of Two Anti TNF α Compounds: Etanercept and 5 Ethyl 1 Phenyl 2 (1H) Pyridone on Secreted and Cell Associated TNF α In Vitro
... protein-based anti- TNF-α drugs, several laboratories, including our own, have studied pyridone-based small molecules with the intent of targeting excessive TNF-α production in in- flammatory ...
10
Attenuation of inflammatory polyarthritis in TNF transgenic mice by diacerein: comparative analysis with dexamethasone, methotrexate and anti TNF protocols
... of anti-inflammatory agents (i.e. dex- amethasone, methotrexate, and an anti-TNF antibody) that are used in patients with chronic inflammatory arthritides, including ...or anti-TNF had ...
8
Anti-TNF inhibits the Airways neutrophilic inflammation induced by inhaled endotoxin in human
... the TNF-α axis since they had increased expression of membrane-bound TNF-α, TNF-α receptor 1, and TNF-α–converting enzyme by peripheral-blood monocytes and a 10 weeks of treatment with the ...
10
Clinical use of anti-TNF therapy and increased risk of infections
... presentation. Disseminated disease is most frequently asso- ciated with immunocompromised states, as seen in patients with hematologic malignancies, hematopoietic cell trans- plantation, solid organ transplantation, or ...
21
Anti-TNF therapy for juvenile idiopathic arthritis-related uveitis
... of 40 mg every 2 weeks. Three patients who would not have been compliant with adalimumab, received intrave- nous infliximab at the dose of 5 mg/kg at baseline, after 2 and 6 weeks, and then every 6 to 8 weeks. Before ...
8
The use of anti-TNFα medications for rheumatologic disease in pregnancy
... human breastmilk is IgA, which provides mucosal immunity in the gut of the infant. Little IgG or other large immunoglobulins cross into breastmilk and these do not enter infant circulation in significant amounts. For ...
11
Original Article The potential of TNF and TNFRSF1B gene polymorphism in predicting the clinical response of anti-TNF therapy in patients with juvenile idiopathic arthritis
... of TNF inhibitors. Frequencies of TNF- 308 GG (rs1800629) and TT TNFRSF1B (rs1061622) were found to be increased in responders group compared with non-resp- onders group, which indicating the potential ...
8
Endothelial progenitor cell levels in juvenile idiopathic arthritis patients; effects of anti-inflammatory therapies
... introduction of varying regimens based on administra- tion of anti-inflammatory drugs including methotrexate, glucocorticoid and anti-TNF-alpha monoclonal anti- bodies. Again, vast majority of ...
8
Chronic TNF-α Neutralization Does Not Improve Insulin Resistance or Endothelial Function in “Healthy” Men with Metabolic Syndrome
... to TNF-α neu- ...of TNF-α neutralization, thus potentially not allowing sufficient time for normal- ...of TNF-α antagonist. It has been pointed out that the anti-TNF mono- clonal ...
5
Characterization in vitro of a human tumor necrosis factor binding protein A soluble form of a tumor necrosis factor receptor
... 30-kD TNF-binding protein (TNF-BP) purified from urine may have a role in regulation because it protects in vitro against the biological effects of ...of TNF on the fibrosarcoma cell line WEHI 164 ...
8
“Serious skin & soft tissue infections in rheumatoid arthritis patients taking anti tumor necrosis factor alpha drugs: a nested case–control study”
... between anti- TNF drug treatment and an increase in all serious infec- tions in RA patients ...between anti-TNF therapy and increased risk of infection in RA patients ...receiving ...
7
Circulating natural antibodies to inflammatory cytokines are potential biomarkers for atherosclerosis
... to TNF α -1(adjusted r 2 = ...increased anti-TNF α -1 IgG levels (adjusted r 2 = ...and anti-IL1 α IgG levels (adjusted r 2 = ...higher anti-IL1 β -2 IgG levels than controls (adjusted ...
6
Estimating the returns to United Kingdom publicly funded musculoskeletal disease research in terms of net value of improved health outcomes
... Charities; Anti-TNF: anti-tumour necrosis factor drugs; ARUK: Arthritis Research UK; bDMARDs: biologic disease-modifying anti rheumatic drugs; cDMARDs: conventional disease- modifying ...
24